Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.
Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators. Kojima S, et al. Among authors: hisatome i. Rheumatology (Oxford). 2022 May 30;61(6):2346-2359. doi: 10.1093/rheumatology/keab739. Rheumatology (Oxford). 2022. PMID: 34605897 Clinical Trial.
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
Kohagura K, Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators. Kohagura K, et al. Among authors: hisatome i. Hypertens Res. 2023 Jun;46(6):1417-1422. doi: 10.1038/s41440-023-01198-x. Epub 2023 Feb 7. Hypertens Res. 2023. PMID: 36750608 Clinical Trial.
Update in uric acid, hypertension, and cardiovascular diseases.
Kuwabara M, Kodama T, Ae R, Kanbay M, Andres-Hernando A, Borghi C, Hisatome I, Lanaspa MA. Kuwabara M, et al. Among authors: hisatome i. Hypertens Res. 2023 Jul;46(7):1714-1726. doi: 10.1038/s41440-023-01273-3. Epub 2023 Apr 18. Hypertens Res. 2023. PMID: 37072573 Review.
Tips and pitfalls in uric acid clinical research.
Kuwabara M, Kanbay M, Hisatome I. Kuwabara M, et al. Among authors: hisatome i. Hypertens Res. 2023 Mar;46(3):771-773. doi: 10.1038/s41440-022-01148-z. Epub 2022 Dec 28. Hypertens Res. 2023. PMID: 36577846 No abstract available.
Dysuricemia-A New Concept Encompassing Hyperuricemia and Hypouricemia.
Otani N, Ouchi M, Mizuta E, Morita A, Fujita T, Anzai N, Hisatome I. Otani N, et al. Among authors: hisatome i. Biomedicines. 2023 Apr 23;11(5):1255. doi: 10.3390/biomedicines11051255. Biomedicines. 2023. PMID: 37238926 Free PMC article. Review.
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled Trial.
Sugawara M, Kojima S, Hisatome I, Matsui K, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Mori H, Tsujita K, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy (FREED) investigators. Sugawara M, et al. Among authors: hisatome i. Clin Pharmacol Ther. 2024 Feb 23. doi: 10.1002/cpt.3217. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38389505
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.
Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M, Maruhashi T, Tanaka A, Morikawa N, Nishimiya K, Akashi N, Tanaka Y, Otani N, Morita M, Miyata H, Takada T, Tsutani H, Ogino K, Ichida K, Hisatome I, Abe K. Kuwabara M, et al. Among authors: hisatome i. Biomolecules. 2023 Oct 13;13(10):1519. doi: 10.3390/biom13101519. Biomolecules. 2023. PMID: 37892201 Free PMC article. Review.
CORRIGENDUM: β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.
Adachi M, Watanabe M, Kurata Y, Inoue Y, Notsu T, Yamamoto K, Horie H, Tanno S, Morita M, Miake J, Hamada T, Kuwabara M, Nakasone N, Ninomiya H, Tsuneto M, Shirayoshi Y, Yoshida A, Nishimura M, Yamamoto K, Hisatome I. Adachi M, et al. Among authors: hisatome i. Circ J. 2023;87(10):1622. doi: 10.1253/circj.CJ-66-0217. Circ J. 2023. PMID: 37743528 Free article. No abstract available.
373 results